↓ Skip to main content

Landiolol, an ultra-short acting beta-1 blocker, for preventing postoperative lung cancer recurrence: study protocol for a phase III, multicenter randomized trial with two parallel groups of patients

Overview of attention for article published in Trials, December 2019
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
29 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Landiolol, an ultra-short acting beta-1 blocker, for preventing postoperative lung cancer recurrence: study protocol for a phase III, multicenter randomized trial with two parallel groups of patients
Published in
Trials, December 2019
DOI 10.1186/s13063-019-3904-4
Pubmed ID
Authors

Haruko Yamamoto, Toshimitsu Hamasaki, Kaori Onda, Takashi Nojiri, Masato Aragaki, Nao Horie, Norihiro Sato, Yasuhiro Hida

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 29 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 7 24%
Student > Master 3 10%
Student > Bachelor 2 7%
Other 1 3%
Student > Doctoral Student 1 3%
Other 2 7%
Unknown 13 45%
Readers by discipline Count As %
Unspecified 7 24%
Medicine and Dentistry 4 14%
Nursing and Health Professions 1 3%
Biochemistry, Genetics and Molecular Biology 1 3%
Unknown 16 55%